• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Page Path

2
results for

"Type 2 diabetes mellitus"

Filter

Article category

Keywords

Publication year

Authors

"Type 2 diabetes mellitus"

Case Report

[English]
Paroxetine-induced Hypoglycemia in Type 2 Diabetic Patient
Seunghee Han, Hye-Sun Park, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
Ewha Med J 2016;39(1):14-16.   Published online January 29, 2016
DOI: https://doi.org/10.12771/emj.2016.39.1.14

Selective serotonin reuptake inhibitors are commonly prescribed drugs for the treatment of depression in the patients with diabetes. Here, we report a case of paroxetineinduced severe recurrent hypoglycemia that developed in a 35-year-old woman with poorly controlled type 2 diabetes complicated by diabetic nephropathy and neuropathy. She discontinued her daily insulin therapy 2 months after the introduction of paroxetine, but hypoglycemic events were sustained. After discontinuation of paroxetine, no more hypoglycemic events occurred.

Citations

Citations to this article as recorded by  
  • Pharmacological treatment for mental health illnesses in adults receiving dialysis: A scoping review
    Jenny Wichart, Peter Yoeun, Tracy Chin, Christopher Evernden, Charlotte Berendonk, Jodi Kerr, Alexandra Birchall, Belinda Boschee, Kimberly Defoe, Jasleen Dhaliwal, Tasia KarisAllen, Megan Kennedy, Alexis McDonald, Monika K. Mierzejewski, Kara Schick‐Maka
    Fundamental & Clinical Pharmacology.2024; 38(5): 862.     CrossRef
  • Paroxetine

    Reactions Weekly.2016; 1597(1): 166.     CrossRef
  • 119 View
  • 4 Download
  • 2 Crossref
Original Article
[English]
Decreased Insulin Secretion in Women with Previous Gestational Diabetes Mellitus
Yoon Pyo Lee, Soo Kyung Lim, Ji young Chang, Eun kyo Jung, Youn-i Choi, Jee-Young Oh, Youngsun Hong, Yeon-Ah Sung, Hyejin Lee
Ewha Med J 2015;38(1):30-35.   Published online March 26, 2015
DOI: https://doi.org/10.12771/emj.2015.38.1.30
Objectives

Gestational diabetes mellitus (GDM) affects 2%-4% of the all pregnant women, and it is a major risk factor for development of type 2 DM. We performed this cross-sectional study to determine whether there were defects in insulin secretory capacity or insulin sensitivity in women with previous GDM.

Methods

On 6-8 weeks after delivery, 75 g oral glucose tolerance test was performed in 36 women with previous GDM and 19 non-pregnant control women matched with age and weight. Intravenous glucose tolerance test was performed on 10-14 weeks after delivery. Insulin secretory capacity measured as the acute insulin response to glucose (AIRg) and insulin sensitivity as minimal model derived sensitivity index (SI) were obtained. AIRg×SI (β-cell disposition index) was used as an index of β-cell function.

Results

Women with previous GDM were classified into normal glucose tolerance (postpartum-NGT, n=19) and impaired glucose tolerance (postpartum-IGT, n=17). Postpartum fasting glucose levels were significantly higher in postpartum-IGT compared to postpartum-NGT and control (P<0.05). AIRg×SI was significantly lower in postpartum-IGT compared to control (P<0.05). SI was lower in postpartum-NGT and postpartum-IGT compared to control, but the difference did not have the statistical significance. Frequency of parental history of type 2 diabetes was significantly greater in postpartum-IGT compared to postpartum-NGT (P<0.05).

Conclusion

Women with previous GDM showed impaired insulin secretion although their glucose tolerance states were restored to normal. It suggests impaired early insulin secretion may be a major pathophysiologic factor for development of type 2 DM, and this defect may be genetically determined.

  • 77 View
  • 0 Download
TOP